Sandya L. Ananth

BCX-1812 (RWJ-270201):  Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor through Structure-Based Drug Design

Y.S. Babu, Pooran Chand, Shanta Bantia et al. · Journal of Medicinal Chemistry · 2000 · 376 citations · Full text

Crystal Structure, Medicinal Chemistry, Antimicrobial Drug Discovery +15

Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir

Shanta Bantia, Cynthia Parker, Sandya L. Ananth et al. · Antimicrobial Agents and Chemotherapy · 2001 · 148 citations · Full text

Medicinal Chemistry, Drug Discovery, Influenza Virus Neuraminidase +15

Purine nucleoside phosphorylase inhibitor BCX-1777 (Immucillin-H)—a novel potent and orally active immunosuppressive agent

Shanta Bantia, Patrick J. Miller, Cynthia Parker et al. · International Immunopharmacology · 2001 · 88 citations

Active Immunosuppressive Agent, Medicine, Immunosuppressive Therapy +7

Identification of <i>gmhA</i> , a <i>Yersinia pestis</i> Gene Required for Flea Blockage, by Using a <i>Caenorhabditis elegans</i> Biofilm System

Creg Darby, Sandya L. Ananth, Tan Li Peng et al. · Infection and Immunity · 2005 · 81 citations · Full text

Medical Microbiology, Flea Blockage, Microbial Pathogens +14

Mechanism of inhibition of T-acute lymphoblastic leukemia cells by PNP inhibitor—BCX-1777

Shanta Bantia, Sandya L. Ananth, Cynthia Parker et al. · International Immunopharmacology · 2003 · 78 citations

Hematological Malignancy, Immunology, Adult T-cell Leukemia-lymphoma +3